4th Rx-to-OTC Switch Summit Switching drugs from prescription (Rx) to over-the-counter (OTC) status is a commercial strategy that has been growing in popularity. More than 20 products have been switched over to OTC during the past decade � and there has been a plethora of high-profile switch failures and disappointing results.

Date : 4th December 2017 to 5th December 2017

Place : United States, Philadepia

Website :https://www.eventbrite.com/e/4th-rx-to-otc-switch-summit-exl-tickets-34325082245?aff=NDT

Contact Person:Paula Edwards

Description:

4th Rx-to-OTC Switch Summit Switching drugs from prescription (Rx) to over-the-counter (OTC) status is a commercial strategy that has been growing in popularity. More than 20 products have been switched over to OTC during the past decade — and there has been a plethora of high-profile switch failures and disappointing results.

4th Rx-to-OTC Switch Summit Switching drugs from prescription (Rx) to over-the-counter (OTC) status is a commercial strategy that has been growing in popularity. More than 20 products have been switched over to OTC during the past decade � and there has been a plethora of high-profile switch failures and disappointing results. will be held in Philadepia,United States on date 2017-12-05

---

Deadline for abstracts/proposals : 1st December 2017

Keynote Speakers :

Conference Highlights :Explore current trends and business models, and identify how to lead your Rx drug through the OTC switch journey Review the latest switches and learn from examples of successful and failed switches, as well as what caused their outcomes Hear how industry stakeholders can work together with key stakeholders — such as the FDA, retailers and government agencies — on the switch process and discuss the latest regulatory challenges and initiatives, including NSURE

Venue :Philadelphia, PA, United States

Check the event website for more details.